<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7335243\results\search\drug\results.xml">
  <result pre="the lipid or sterol metabolism, regulation of neurotransmitters, kinase signaling," exact="estrogen" post="receptors, and DNA synthesis/repair) [70], [71], [72], [73]. It"/>
  <result pre="Manufacturer Status of clinical trials Nucleoside Analogs Pegylated interferon with" exact="ribavirin" post="[77] / Valeant Under clinical trial for COVID-19 (ChiCTR2000029387)"/>
  <result pre="Under clinical trial for COVID-19 (ChiCTR2000029548) Remdesivir [79] (GS-5734) An" exact="adenine" post="analog with a similar chemical structure to the approved"/>
  <result pre="similar chemical structure to the approved HIV reverse transcriptase inhibitor" exact="tenofovir alafenamide." post="Gilead Phase II clinical trial for Ebola(NCT03719586);Under phase III"/>
  <result pre="of COVID-19 in the early stage Protease inhibitors Lopinavir and" exact="ritonavir" post="[76] Protease inhibitors approved as anti-HIV drugs Abbott Under"/>
  <result pre="clinical trials for SARS; Under clinical trial for COVID-19 (ChiCTR2000029539)" exact="Chloroquine" post="Chloroquine and hydroxychloroquine [81] Oral prescription drugs for treatment"/>
  <result pre="trials for SARS; Under clinical trial for COVID-19 (ChiCTR2000029539) Chloroquine" exact="Chloroquine" post="and hydroxychloroquine [81] Oral prescription drugs for treatment of"/>
  <result pre="SARS; Under clinical trial for COVID-19 (ChiCTR2000029539) Chloroquine Chloroquine and" exact="hydroxychloroquine" post="[81] Oral prescription drugs for treatment of malaria and"/>
  <result pre="RdRp, nucleoside analogs are responsible for viral RNA replication [84]." exact="Ribavirin" post="is a guanine analog among approved nucleoside analogs used"/>
  <result pre="and has been harnessed to cure patients with SARS [85]." exact="Ribavirin" post="was extensively leveraged for patients with or without concomitant"/>
  <result pre="reactions like anemia in high doses [77]. In COVID-19 therapy," exact="ribavirin" post="was utilized with pegylated interferon for stimulating the innate"/>
  <result pre="with other antiviral drugs like baloxavir marboxil [88]. As an" exact="adenine" post="analogue with a similar chemical structure to the approved"/>
  <result pre="similar chemical structure to the approved HIV reverse transcriptase inhibitor" exact="tenofovir alafenamide," post="remdesivir (GS-5734) exhibits broad-spectrum antiviral activity against several RNA"/>
  <result pre="It also possesses outstanding in vitro antiviral activity compared with" exact="lopinavir" post="and ritonavir [90]. In the United States, the first"/>
  <result pre="possesses outstanding in vitro antiviral activity compared with lopinavir and" exact="ritonavir" post="[90]. In the United States, the first case of"/>
  <result pre="of IFN-Î± via vapor inhalation in patients twice daily with" exact="ribavirin" post="as combined therapy [96]. In the detailed study of"/>
  <result pre="to the standard-care group. Further, Baden and Rubin unraveled that" exact="lopinavir" post="simply was not particularly potent against SARS-CoV-2. The concentration"/>
  <result pre="SARS-CoV, indicating an alternative therapeutic option for COVID-19 [76]. 5.3.2" exact="Chloroquine" post="and hydroxychloroquine Chloroquine, as a drug extensively utilized in"/>
  <result pre="an alternative therapeutic option for COVID-19 [76]. 5.3.2 Chloroquine and" exact="hydroxychloroquine" post="Chloroquine, as a drug extensively utilized in anti-malaria and"/>
  <result pre="of SARS-CoV cell receptors [101]. Gao et al. revealed that" exact="chloroquine" post="was effective in the therapy of COVID-19-associated pneumonia [102]."/>
  <result pre="of around 1â€¯Î¼M [88]. Although several trials had verified that" exact="chloroquine" post="suppresses the exacerbation of COVID-19, the optimal dosage of"/>
  <result pre="chloroquine suppresses the exacerbation of COVID-19, the optimal dosage of" exact="chloroquine" post="will require to be evaluated in future trials [102]."/>
  <result pre="chloroquine will require to be evaluated in future trials [102]." exact="Hydroxychloroquine" post="is an analog of chloroquine, and there are few"/>
  <result pre="few studies on its interaction [103]. In previous SARS outbreaks," exact="hydroxychloroquine" post="was found to possess anti-SARS-CoV capacity in vitro[104]. In"/>
  <result pre="by applying a physiologically based pharmacokinetic model, they found that" exact="hydroxychloroquine" post="is more effective than chloroquine in Vero cells infected"/>
  <result pre="pharmacokinetic model, they found that hydroxychloroquine is more effective than" exact="chloroquine" post="in Vero cells infected with SARS-CoV-2 [105]. Of note,"/>
  <result pre="in turn cause multiple organ failure and death [49]. Both" exact="chloroquine" post="and hydroxychloroquine possess immunomodulatory effects and can inhibit such"/>
  <result pre="cause multiple organ failure and death [49]. Both chloroquine and" exact="hydroxychloroquine" post="possess immunomodulatory effects and can inhibit such immune responses"/>
  <result pre="may relate with the determination of whether the benefit of" exact="chloroquine" post="treatment is hinged on the age of the patients"/>
  <result pre="[107]. Recently, a multinational registry analysis of the application of" exact="hydroxychloroquine" post="or chloroquine unraveled that there might be an increased"/>
  <result pre="a multinational registry analysis of the application of hydroxychloroquine or" exact="chloroquine" post="unraveled that there might be an increased frequency of"/>
  <result pre="treatment of COVID-19 diseases [108]. The WHO has also suspended" exact="hydroxychloroquine" post="treatment in COVID-19 solidarity trial in terms of the"/>
  <result pre="of SARS: initial virological and clinical findingsThorax59200425225614985565 76YamamotoN.YangR.YoshinakaY.AmariS.NakanoT.CinatlJ.HIV protease inhibitor" exact="nelfinavir" post="inhibits replication of SARS-associated coronavirusBiochem Biophys Res Commun318200471972515144898 77Al-TawfiqJ.A.MomattinH.DibJ.MemishZ.A.Ribavirin"/>
  <result pre="depletion of cellular GTP pools and is moderately synergistic with" exact="alpha" post="interferonAntimicrob Agents Chemother58201426727324145541 85SoL.K.Y.LauA.C.W.YamL.Y.C.CheungT.M.T.PoonE.YungR.W.H.Development of a standard treatment protocol"/>
  <result pre="animal and human cell linesBiochem Biophys Res Commun326200590590815607755 88WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="potent inhibitor of SARS coronavirus infection and spreadVirol J220056916115318 102GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="COVID-19 associated pneumonia in clinical studiesBiosci Trends4120207273 103JallouliM.GalicierL.ZahrN.AumaitreO.FrancesC.Le GuernV.Determinants of" exact="hydroxychloroquine" post="blood concentration variations in systemic lupus erythematosusArthritis Rheumatol6720152176218425989906 104BiotC.DaherW.ChavainN.FandeurT.KhalifeJ.DiveD.Design"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020ciaa237 106SchrezenmeierE.DÃ¶rnerT.Mechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatologyNat Rev Rheumatol16202015516632034323 107TouretF.de LamballerieX.Of"/>
  <result pre="hydroxychloroquine and chloroquine: implications for rheumatologyNat Rev Rheumatol16202015516632034323 107TouretF.de LamballerieX.Of" exact="chloroquine" post="and COVID-19Antiviral Res2020104762 108MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Hydroxychloroquine or chloroquine with or without"/>
  <result pre="Rev Rheumatol16202015516632034323 107TouretF.de LamballerieX.Of chloroquine and COVID-19Antiviral Res2020104762 108MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
  <result pre="treatment of COVID-19: a multinational registry analysisLancet202010.1016/S0140-6736(20)31180-6 109Kunzmann K.A.WHO suspends" exact="hydroxychloroquine" post="treatment in COVID-19 solidarity trial2020. https://www.contagionlive.com/news/who-hydroxychloroquine-treatment-covid-19-solidarity-trial. 110JeanS.S.LeeP.I.HsuehP.R.Treatment options for"/>
 </snippets>
</snippetsTree>
